ABSTRACT

Fact Sheet for Healthcare Providers: Beckman Coulter, Inc., Access SARS‐CoV‐2 IgM   [open pdf - 173KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Access SARS‐CoV‐2 [severe acute respiratory syndrome coronavirus 2] IgM [Immunoglobulin M]. [...] The Access SARS‐CoV‐2 IgM is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma."

Publisher:
Date:
2020-10-08
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations